Trade SPRB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Spruce Biosciences, Inc. (SPRB) is trading at US$53.70, down 1.20% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$148.24M. Over the past 52 weeks, SPRB has traded between US$7.26 and US$240.00. On Syfe you can trade SPRB with $0 commission and add it to your watchlist.
| Previous close | US$54.35 |
|---|---|
| Market cap | US$148.24M |
| 52-week range | US$7.26 – US$240.00 |
| Volume | 88.4K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Spruce Biosciences, Inc.
Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.
Year: 2020
B. Riley Initiates Spruce Biosciences at Buy With $160 Price Target
Jul 13, 12:27 PM · MT Newswires
Spruce Biosciences Reports Long-Term Data for Enzyme Replacement Therapy to Treat Genetic Disease MPS IIIB
Jun 8, 9:45 PM · MT Newswires
Top Midday Decliners
Apr 21, 4:55 PM · MT Newswires
Top Premarket Decliners
Apr 21, 11:57 AM · MT Newswires
Spruce Biosciences Begins Public Offering of Stock, Prefunded Warrants; Shares Fall After Hours
Apr 20, 9:54 PM · MT Newswires
Spruce Biosciences, Inc. (SPRB) stock is trading at US$53.70, -1.20% from the previous close of US$54.35.
The market cap for Spruce Biosciences, Inc. (SPRB) stock is approximately US$148.24M.
The 52-week high for Spruce Biosciences, Inc. (SPRB) stock is US$240.00.
The 52-week low for Spruce Biosciences, Inc. (SPRB) stock is US$7.26.
Spruce Biosciences, Inc. (SPRB) does not currently pay a dividend.
Stay on top of SPRB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
